Who to call at CNBX Pharmaceuticals Inc., and when
Fundz watches for the moments CNBX Pharmaceuticals Inc. starts buying, and tells you who to reach.
- An alert the day CNBX Pharmaceuticals Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CNBX Pharmaceuticals Inc., from your own LinkedIn network
CNBX Pharmaceuticals Inc.
The company changed its auditor. An 8-K is the notice a US public company must file within four business days of a major event.
AI Executive Summary
AI-powered analysis of 8-K filing content
CNBX Pharmaceuticals dismissed its independent auditor Elkana Amitai CPA and appointed Vilki & Co. as its new accounting firm effective September 28, 2026. The change was not due to disagreement and the prior auditor's reports included going concern warnings, which may signal financial stress that investors should monitor.
Key Takeaways
Auditor change was not due to disagreement on accounting principles, practices, or audit scope
Prior auditor's reports for fiscal years 2024 and 2025 included substantial doubt about going concern, indicating potential financial distress
2 more takeaways
Filing Overview
What This Means
CNBX Pharmaceuticals Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.